Insights

Consolidation Momentum Orbillion Bio is now part of Nexture Bio following a prior acquisition by Fork & Good, signaling ongoing consolidation in the cultivated meat space and creating a channel to reach customers through the acquirers' sales and manufacturing networks. Sales opportunities include co-selling Orbillion's scale-up platform and integrating it into the acquirers' service offerings, as well as partnering with their existing customer base and suppliers.

Global Market Access Past partnerships show regional expansion momentum, including a Europe rollout with Luiten Food to reach multiple countries and a collaboration with Solar Biotech to scale production. This indicates demand across regions and creates opportunities to pursue distribution partnerships, regulatory support, and joint go-to-market arrangements with large meat brands and distributors.

Scale-Up Advantage Orbillion highlights a proprietary scale-up algorithm for cultivated beef and AI-driven bioprocess capabilities via Solar Biotech. This differentiation provides sales angles for licensing, process development contracts, or system integration services to other cultivated meat producers, contract manufacturers, or ingredient suppliers seeking to lower production costs and accelerate scaling.

Acquirer Networks With acquisition by Nexture Bio, there is a built-in channel to access a broader customer base and procurement networks. This creates opportunities for joint go-to-market efforts, pilot programs, and rapid deployment of Orbillion's technology through the acquirer’s platforms and partnerships.

Lean Partner Fit Early-stage economics and a lean team, backed by notable venture investors, suggest a high-velocity partnership approach with external CMOs, equipment vendors, or regulatory and compliance firms. Potential sales avenues include co-development contracts, equipment integration deals, and revenue-sharing pilots that leverage Orbillion’s technology without long internal development cycles.

Orbillion Bio [Acquired] Tech Stack

Orbillion Bio [Acquired] uses 8 technology products and services including MATLAB, Facebook Pixel, Amazon Web Services, and more. Explore Orbillion Bio [Acquired]'s tech stack below.

  • MATLAB
    Advanced Analytics And Data Science
  • Facebook Pixel
    Analytics
  • Amazon Web Services
    Cloud Hosting
  • Squarespace
    Content Management System
  • Open Graph
    Content Management System
  • Google Fonts API
    Font Scripts
  • Emotion
    Javascript Frameworks
  • HSTS
    Security

Media & News

Orbillion Bio [Acquired]'s Email Address Formats

Orbillion Bio [Acquired] uses at least 1 format(s):
Orbillion Bio [Acquired] Email FormatsExamplePercentage
FirstL@orbillion.comJohnD@orbillion.com
100%

Frequently Asked Questions

What is Orbillion Bio [Acquired]'s official website and social media links?

Minus sign iconPlus sign icon
Orbillion Bio [Acquired]'s official website is orbillion.com and has social profiles on LinkedInCrunchbase.

What is Orbillion Bio [Acquired]'s SIC code NAICS code?

Minus sign iconPlus sign icon
Orbillion Bio [Acquired]'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Orbillion Bio [Acquired] have currently?

Minus sign iconPlus sign icon
As of July 2026, Orbillion Bio [Acquired] has approximately 9 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Investor: S. B.Investor: Y. J.. Explore Orbillion Bio [Acquired]'s employee directory with LeadIQ.

What industry does Orbillion Bio [Acquired] belong to?

Minus sign iconPlus sign icon
Orbillion Bio [Acquired] operates in the Biotechnology Research industry.

What technology does Orbillion Bio [Acquired] use?

Minus sign iconPlus sign icon
Orbillion Bio [Acquired]'s tech stack includes MATLABFacebook PixelAmazon Web ServicesSquarespaceOpen GraphGoogle Fonts APIEmotionHSTS.

What is Orbillion Bio [Acquired]'s email format?

Minus sign iconPlus sign icon
Orbillion Bio [Acquired]'s email format typically follows the pattern of FirstL@orbillion.com. Find more Orbillion Bio [Acquired] email formats with LeadIQ.

How much funding has Orbillion Bio [Acquired] raised to date?

Minus sign iconPlus sign icon
As of July 2026, Orbillion Bio [Acquired] has raised $5.1M in funding. The last funding round occurred on Mar 14, 2024.

When was Orbillion Bio [Acquired] founded?

Minus sign iconPlus sign icon
Orbillion Bio [Acquired] was founded in 2019.
Orbillion Bio [Acquired] logo

Orbillion Bio [Acquired]

Biotechnology ResearchCalifornia, United States2-10 Employees

Orbillion Bio is a biotechnology research company based in San Francisco, California. It operates as a B2B cultivated meat technology company with a focus on bringing meat to the global ground beef market, which is valued at approximately $211 billion, and has developed a scale-up algorithm intended to lower production costs for cultivated beef. The organization employs between 2 and 10 people. The founders bring more than 35 years of combined biopharma bioprocessing experience, contributing to the development and commercialization of cultivated meat systems. It has backing from investors including The Venture Collective, Y Combinator, At One Ventures, Venture Souq, and Metaplanet. Reports indicate the company was acquired by Fork & Good Inc. in October 2025 and subsequently by Nexture Bio, Inc. in April 2026.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
2-10

Section iconFunding & Financials

  • $5.1M

    Orbillion Bio [Acquired] has raised a total of $5.1M of funding over 9 rounds. Their latest funding round was raised on Mar 14, 2024as a series_unknown.

  • $1M

    Orbillion Bio [Acquired]'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $5.1M

    Orbillion Bio [Acquired] has raised a total of $5.1M of funding over 9 rounds. Their latest funding round was raised on Mar 14, 2024as a series_unknown.

  • $1M

    Orbillion Bio [Acquired]'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.